AMID RESEARCH SYMPOSIA dedicated to precise and exacting approaches to cancer—such as targeted therapies, checkpoint inhibitors and genomic testing—the American Association for Cancer Research brought together seven experts to characterize a complex topic in its own right: cancer survivorship.
Panelists, some of whom had been diagnosed with cancer, discussed the unique challenges facing cancer survivors—a population estimated to grow from 16.5 million to up to 20 million by 2026.
“If you start looking at the number of survivors who are in their 80s and 90s, [the rise in this population is] something that we’ve never seen before,” said Anna C. Barker, who opened the April 15 panel discussion at the American Association for Cancer Research Annual Meeting with a definition of survivors, noting the term included those who are diagnosed with cancer, being treated for it or living beyond those treatments.
No comments:
Post a Comment